Histo-clinical factors which have an influence on prognosis in gastric cancer;Czynnik histo-kliniczne wpływajace na rokowanie w raku ż oładka

Onkologia Polska

Volumn 7, Issue 3, 2004, Pages 147-151

  Tenderenda, Michał ^a   Wroński, Konrad ^a  

^a Klinika Chirurgii Onkologicznej   (Poland)

Author keywords

Gastric cancer; Prognostic factors

Indexed keywords

AGE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; PROGNOSIS; REVIEW; SEX DIFFERENCE; STOMACH CANCER; SURVIVAL TIME;

EID: 13244273464     PISSN: 15056732     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Fraczek M.: Nowotwory żoładka. [w:] Nowotwory przewodu pokarmowego, Krawczyk M. (red.). PZWL, Warszawa 2001, 144-189.
2. Heberer G., Teichmann R.K., Kramling H.J.: Result of gastric resection for carcinoma of the stomach: The European Experience World J. Surg. 1988, 12, 374-381.
3. Popiela T., Kulig J., Berner J. i wsp.: Wieloczynnikowe leczenie szansa na poprawe wyników leczenia raka żoladka w Polsce Nowotwory 1996, 46, supl. 1, 28-74.
4. Szawłowski A., Jeziorski K.: Nowotwory złośliwe górnego odcinka przewodu pokarmowego. [w:] Onkologia kliniczna t. II, Krzakowski M. (red.). Warszawa 2001, 194-236.
5. Martin J.G.: Staging of esophageal and gastric carcinoma [w:] Management of upper gastrointestinal cancer, Daly J.M., Hennessy T.P.J., Reynolds J.V. (red.). W.B. Saunders Co. Ltd., Nowy Jork 1999, 3.
6. Reed P.J.: Early gastric cancer: follow-up after gastrectomy in 159 patients. Br. J. Surg. 1993, 80, 325-328.
7. Roder J.D., Bottcher K., Siewert J.R. i wsp.: Prognostic factors in gastric carcinoma. Results of the German gastric carcinoma study 1992. Cancer 1993, 72, 2089-2097.
8. Compan A.F., Medfranc J.: Gastric carcinoma: study of the most eminent prognostic factors. Eur. J. Surg. Oncol. 1993, 19, 533-538.
9. Nakomura K., Ueyama T.: Pathology and prognosis of gastric carcinoma. Cancer 1992, 70, 1030-1037.
10. Hallissey M.T., Fielding J.W.: Badania przesiewowe w raku żoładka. Chir. Współ. 1994, 2, 70.
11. Sano T., Sasako M.: Recurrence of early gastric cancer. Cancer 1993, 72, 3174-3178.
12. Evrard S., Marescaux J., Johnson C.D.: Gruczolakorak żoładka w krajach zachodnich a doświadczenia chirurgów japońskich. Chir. Współ. 1993, 6, 359-366.
13. Bruckner H.W., Kondo T., Kondo K.: Neoplasms of the stomach. [w:] Cancer medicine, Holland J.F., Bast R.C., Morton P.L. Williams and Wilkins, Baltimore-Filadelfia-Londyn-Paryż-Bangkok-Buenos Aires-Hong Kong-Monachium-Sydney-Tokio-Wrocław 1997.
14. Wastel C.: Gastric cancer. [w:] Essential general surgical oncology, Taylor J., Cooke T.G., Guillon P. (red.). Churchil Livingstone, Nowy Jork-Edinburgh-Londyn-Madryt-Melbourne-San Francisco-Tokio 1996.
15. Sawai K., Takahashi T., Suzuki H.: New trends in syrgery for gastric cancer in Japan. J. Surg. Oncol. 1994, 56, 221-226.
16. Barber K.W., Gage P., Priesley J.T.: Significance duration of symptoms and size of lesion in prognosis of gastric carcinoma. Surg. Gynecol. Obstet. 1961, 113, 673-678.
17. Cady B., Ramsden D.A.: Treatment of gastric cancer. Surg. Clin. North Am. 1976, 563, 599-605.
18. Goldenberg J.A., Cohen J.M., Skinner D.G.: A study of survival patterns in patients with gastric carcinoma. Surg. Gynecol. Obstet. 1967, 126, 241.
19. Inberg M.V., Heinonen R., Viikari J.: Total and proximal gastrectomy in the treatment of gastric carcinoma: a series of 305 cases World J. Surg. 1981, 5, 249-257.
20. Oshiba S., Ueno K., Mochizuki F., Yamagata S.: Histoclinical classification and follow-up study of gastric polyp. Tohoku J. Exp. Med. 1976, 118, 19-22.
21. Kodama Y., Inokuchi K., Okamura T. i wsp.: Groth patterns and prognosis in early gastric carcinoma. Cancer 1983, 51, 320-326.
22. Kodama Y., Sugimachi K., Soejima K. i wsp.: Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J. Surg. 1981, 5, 241-248.
23. Saito A., Ayokoyama M.: The role of lymphadenectomy in curative surgery for gastric cancer. Jpn. Cancer Clin. 1973, 19, 285-290.
24. Soga J., Kobayashi K., Saito J., Muto T.: The role of lymphadenectomy in curative surgery for gastric cancer World J. Surg. 1979, 3, 701-708.
25. Kulig J.: Przebieg kliniczny i rokowanie w raku żoładka. [w:] Rak żoładka, Popiela T. (red. . PZWL, Warszawa 1987, 129-156.
26. Gennari L., Bonfanti G., Salvadori B.: Diagnosis and treatment of upper gastrointestinal tumors. Tumori 1980, 3, 173-183.
27. Dunphy J.E., Way L.W.: Current surgical diagnosis and treatment. Ann. Surg. 1977, 26, 492-494.
28. Dupont B.J., Lee J.R., Burton G.R., Cohn J.: Adenocarcinoma of the stomach: review of 1497 cases. Cancer 1978, 41, 941-947.
29. Keighley M.R.B., Moore J., Roginski C. i wsp.: Incidence and prognosis of N4 node involvement in gastric cancer. Br. J. Surg. 1984, 71, 863-866.
30. Re Mine H.W.: Indications and contrindications for surgery in gastric carcinoma. World J. Surg. 1979, 3, 709-714.
31. Yoshikawa K., Kitoaka H.: Bone metastasis of gastric cancer. Jpn. J. Surg. 1983, 13, 173-176.
32. Stemmermann G., Brown C.: A survival study of intestinal and diffuse types of gastric carcinoma. Cancer 1974, 33, 1190-1195.
33. Kulig J.: Kontrolowane prospektywne badania kliniczne czynników determinujacych wyniki leczenia raka żoł adka. Rozprawa habilitacyjna, AM, Kraków 1990.
34. Alexander H.R., Kelsen D.G., Tepper J.C.: Cancer of the stomach. [w:] Cancer: principles & practice in oncology, De Vita V.T., Hellmann S., Rosenberg S-A. Lippincot-Raven Publisher, Filadelfia 1997.
35. Gabbert H.E., Meier S., Gerharz C.D., Hommel G.: Tumor-cell dissociation at the invasive front: a new prognostic parameter in gastric cancer patients. Int. J. Cancer 1992, 50, 202-207.
36. Maruyama K.: The most important prognostic factors for gastric cancer patiens. A study using univariate and multivariate analyses. Scand. J. Gastroenterol. 1987, 22, supl. 133, 63-68.
37. Bedikian A.Y., Chen T.T., Khankhanian N. i wsp.: The natural history of gastric cancer and prognostic factors influencing survival. J. Clin. Oncol. 1984, 2, 305-310.
38. Cassel P., Robinson J.: Cancer of the stomach: review of 854 patients. Br. J. Surg. 1976, 63, 603-607.
39. Fielding J.W., Ellis D.J., Jones A., Bradby H.: Diagnosis and treatment of upper gastrointestinal tumors. Br. Med. J. 1980, 542, 253-259.
40. Weed T.E., Nuessle W., Oschner A.: Carcinoma of the stomach. Ann. Surg. 1981, 193, 407-413.
41. Kim J.P., Kim Y.W., Yang H.K. i wsp.: Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J. Surg. 1994, 18, 872-878.
42. Siewert J.R., Fink U., Sendler A.: Gastric cancer: current problems in surgery: Gastric cancer. Curr. Probl. Surg. 1997, 34, 837-939.
43. Nakane Y., Okamura S., Akehira K. i wsp.: Correlation of preoperative carcinembryonic antigen levels and prognosis of gastric cancer patients. Cancer 1994, 73, 2703-2708.
44. Onorato Z.N., Ohkura H., Okajima K. i wsp.: Non-anatomic prognostic factors for gastric cancer patients: significance of tumor markers. [w:] Recent advances in management of digestive cancers Takahashi T. (red.). Springer, Berlin 1993.
45. Reiter W., Stieber P., Reuter C. i wsp.: CA 72-4. CEA. CA 19-9 in diagnosis of relapse and metastases and in prognosis of stomach cancer patients. [w:] Current tumor diagnosis: Applications. clinical relevance, research, trends, Klapdor R. (red.). W. Zuckerschwendt, Monachium 1994, 13-16.
46. Schmitt M., Janicke F., Graeft H.: Tumor-associated proteases. Fibrinolysis 1992, 6, supl. 4, 3-26.
47. Nekarda H., Schmitt M., Ulm K. i wsp.: Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res. 1994, 54, 2900-2907.
48. Matsuo K., Kobayashi I., Tsakuba T. i wsp.: Immunohistochemical localisation of cathepsins D and E in human gastric cancer: a possible correlation with local invasive and metastatic activities of carcinoma cells. Hum. Pathol. 1996, 27, 184-190.
49. Yonemura Y., Nojima N., Kaji M. i wsp.: E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma Cancer 1995, 76, 941-953.
50. Yonemura Y., Ninomiya I., Yamaguchi A. i wsp.: Evaluation of immunoreactivity for c-erbB-2 protein as a maker of poor short term prognosis in gastric cancer. Cancer Res. 1991, 51, 1034-1038.
51. Yonemura Y., Ninomiya U., Ohoyama S. i wsp.: Expression of c-erbB-2 protein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma. Cancer 1991, 67, 2914-2918.
52. Uchino S., Tsuda H., Maruyama K. i wsp.: Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients. Cancer 1993, 72, 3179-3184.
53. Tokunaga A., Onda M., Okuda T.: Clinical significance of epidermal growth factor (EGF). EGF receptor and c-erbB-2 in human gastric cancer. Cancer 1995, 75, supl. 6, 1418-1425.
54. Deng G.R., Lui X.H., Wang J.R.: Correlations of mutations of oncogene C-H-ras at codon 12 with metastasis and survival of gastric cancer patients. Oncogene Res. 1991, 6, 33-38.
55. Tahara E.: Molecular biology of gastric cancer. World J. Surg. 1995, 19, 484-490.